Nivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancreatic (GEP) tract or unknown (UK) origin: Preliminary results from the phase II NICE-NEC trial (GETNE T1913)
dc.conference.date | SEP 16-21, 2021 | |
dc.conference.title | Congress of the European-Society-for-Medical-Oncology (ESMO) | |
dc.contributor.author | Riesco-Martinez, M. C. | |
dc.contributor.author | Capdevila, J. | |
dc.contributor.author | Alonso, V. | |
dc.contributor.author | Jimenez-Fonseca, P. | |
dc.contributor.author | Teule, A. | |
dc.contributor.author | Grande, E. | |
dc.contributor.author | Sevilla, I. | |
dc.contributor.author | Benavent Vinuales, M. | |
dc.contributor.author | Alonso-Gordoa, T. | |
dc.contributor.author | Custodio, A. | |
dc.contributor.author | Hernando, J. | |
dc.contributor.author | Polo, E. | |
dc.contributor.author | Castillo Trujillo, O. A. | |
dc.contributor.author | Garcia-Carbonero, R. | |
dc.contributor.authoraffiliation | [Riesco-Martinez, M. C.] Hosp Univ 12 Octubre, Dept Med Oncol, UCM, Imas12, Madrid, Spain | |
dc.contributor.authoraffiliation | [Garcia-Carbonero, R.] Hosp Univ 12 Octubre, Dept Med Oncol, UCM, Imas12, Madrid, Spain | |
dc.contributor.authoraffiliation | [Capdevila, J.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Hernando, J.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Alonso, V.] Hosp Univ Miguel Servet, Inst Aragones Invest Sanitaria, Med Oncol Dept, Zaragoza, Spain | |
dc.contributor.authoraffiliation | [Polo, E.] Hosp Univ Miguel Servet, Inst Aragones Invest Sanitaria, Med Oncol Dept, Zaragoza, Spain | |
dc.contributor.authoraffiliation | [Jimenez-Fonseca, P.] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain | |
dc.contributor.authoraffiliation | [Castillo Trujillo, O. A.] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain | |
dc.contributor.authoraffiliation | [Teule, A.] Inst Catala Oncol ICO IDIBELL, Med Oncol Dept, Lhospitalet De Llobregat, Spain | |
dc.contributor.authoraffiliation | [Grande, E.] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Sevilla, I.] Hosp Univ Reg & Virgen Victoria Malaga, Inst Invest Biomed Malaga IBIMA, Invest Clin & Traslac Canc, Med Oncol Dept, Malaga, Spain | |
dc.contributor.authoraffiliation | [Benavent Vinuales, M.] Univ Hosp Virgen Rocio, Inst Biomed Sevilla IBIS, Med Oncol Dept, Seville, Spain | |
dc.contributor.authoraffiliation | [Alonso-Gordoa, T.] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Custodio, A.] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain | |
dc.contributor.funder | Bristol Myers Squibb (BMS) | |
dc.date.accessioned | 2025-01-07T15:18:03Z | |
dc.date.available | 2025-01-07T15:18:03Z | |
dc.date.issued | 2021-09-21 | |
dc.identifier.doi | 10.1016/j.annonc.2021.08.180 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.annonc.2021.08.180 | |
dc.identifier.uri | https://hdl.handle.net/10668/27026 | |
dc.identifier.wosID | 700527702116 | |
dc.issue.number | 5 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de la Victoria | |
dc.organization | SAS - Hospital Universitario Regional de Málaga | |
dc.organization | Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA) | |
dc.organization | Instituto de Investigación Biomédica de Sevilla (IBIS) | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | S908-S909 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Nivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancreatic (GEP) tract or unknown (UK) origin: Preliminary results from the phase II NICE-NEC trial (GETNE T1913) | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 32 | |
dc.wostype | Meeting Abstract |
Files
Collections
SAS - Hospital Universitario Virgen de la Victoria
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - Hospital Universitario Virgen del Rocío
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - Hospital Universitario Virgen del Rocío